{
    "title": "U.S. FDA declines to approve Alkermes' schizophrenia treatment",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8957635/U-S-FDA-declines-approve-Alkermes-schizophrenia-treatment.html",
    "date": "2020-11-17",
    "keywords": [
        "company",
        "dania",
        "drug",
        "treatment",
        "agency",
        "issue",
        "approval",
        "analyst",
        "drugmaker",
        "tuesday",
        "food",
        "administration",
        "schizophrenia",
        "disorder",
        "tablet",
        "process",
        "manufacturing",
        "site",
        "dependence",
        "market",
        "officer",
        "richard",
        "investor",
        "conference",
        "anticipation",
        "launch",
        "quarter",
        "agencys",
        "health",
        "regulator",
        "brandon",
        "decision",
        "uncertainty",
        "weakness",
        "companys",
        "stock",
        "clarity",
        "pathway",
        "half",
        "vamil",
        "divan",
        "fda",
        "resubmission",
        "class",
        "response",
        "period",
        "reporting",
        "nadeem",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}